Department of Pediatrics, Baylor College of Medicine, Houston, TX; Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Texas Children's Hospital, Houston, TX.
J Pediatr. 2020 Apr;219:202-208. doi: 10.1016/j.jpeds.2019.12.040. Epub 2020 Jan 31.
To characterize barriers to and facilitators of successful iron therapy in young children with iron deficiency anemia (IDA) from an in-depth parental perspective.
Prospective, mixed methods study of children age 9 months to 4 years with a diagnosis of nutritional IDA by clinical history and laboratory criteria and their parents. Clinical data were obtained from the electronic health record. Semistructured interviews focused on knowledge of IDA, clinical effects, experience with iron therapies, and motivation were conducted with the parent who identified as the child's primary caregiver.
Twenty patient-parent dyads completed the study; 80% (n = 16) identified as Hispanic/Latino (white). Patients' median age was 23 months (50% male); median initial hemoglobin concentration was 8.2 g/dL and duration of oral iron therapy was 3 months. Parents' median age was 29 years (85% female); 8 interviews (40%) were conducted in Spanish. Barriers included difficulty in administering oral iron owing to side effects and poor taste. Facilitators included provision of specific instructions; support from healthcare providers and additional caregivers at home; motivation to benefit child's health, which was strengthened by strong emotional reactions (ie, stress, anxiety) to therapy and follow-up; and an appreciation of child's improvement with successful completion of therapy.
Our findings support the need for interventions designed to promote oral iron adherence in children with IDA. Rather than focusing on knowledge content related to IDA, interventions should aim to increase parental motivation by emphasizing the health benefits of adhering to iron therapy and avoiding more invasive interventions.
从深入的父母角度描述缺铁性贫血 (IDA) 幼儿铁治疗成功的障碍和促进因素。
前瞻性混合方法研究,纳入 9 个月至 4 岁有临床病史和实验室标准诊断为营养性 IDA 的儿童及其父母。临床数据来自电子健康记录。半结构化访谈重点关注 IDA 知识、临床效果、铁治疗经验和动机,访谈对象为被确定为孩子主要照顾者的父母。
20 对患儿-家长完成了研究;80%(n=16)为西班牙裔/拉丁裔(白人)。患儿的中位年龄为 23 个月(50%为男性);初始血红蛋白浓度中位数为 8.2g/dL,口服铁治疗持续 3 个月。家长的中位年龄为 29 岁(85%为女性);8 次访谈(40%)以西班牙语进行。障碍包括因副作用和口味不佳导致口服铁剂难以服用。促进因素包括提供具体的指导;医护人员和其他家庭照顾者的支持;为了孩子的健康而产生的动力,这种动力因对治疗和随访的强烈情绪反应(例如,压力、焦虑)而增强;以及对孩子成功完成治疗后改善的欣赏。
我们的研究结果支持需要干预措施来促进 IDA 儿童口服铁剂的依从性。干预措施不应侧重于与 IDA 相关的知识内容,而应通过强调坚持铁剂治疗和避免更具侵入性干预的健康益处来提高家长的动力。